Patient Perspective on Cross-Linking

Learn more about the importance of early diagnosis and treatment from a keratoconus patient and her treating physician.

A General Overview

Corneal cross-linking is a minimally invasive outpatient procedure that combines the use of Photrexa® Viscous (riboflavin 5’-phosphate in 20% dextran ophthalmic solution), Photrexa® (riboflavin 5’-phosphate ophthalmic solution) and the KXL® system for the treatment of progressive keratoconus.

Corneal Cross-Linking: A New Standard of Care for Progressive Keratoconus

Corneal collagen cross-linking is an innovative therapy that has transformed the treatment of progressive keratoconus. Historically, as many as 1 in 5 patients with progressive keratoconus have required a corneal transplant, with more than half needing multiple transplants within 20 years.1, 2

¹Pramanik S, Musch DC, Sutphin JE, Farjo AA. Extended long-term outcomes of penetrating keratoplasty for keratoconus. Ophthalmology 2006;113(9):1633-8.
2Maharana PK, Agarwal K, Jhanji V, Vajpayee RB. Deep anterior lamellar keratoplasty for keratoconus: a review. Eye Contact Lens 2014;40(6):382-9.

Top Questions to Ask Your Eye Doctor Download PDF

FDA Approval

The first and only therapeutic products for corneal cross-linking which have been FDA approved to treat progressive keratoconus.

In April 2016, the FDA approved Photrexa® Viscous (riboflavin 5’-phosphate in 20% dextran ophthalmic solution) and Photrexa® (riboflavin 5’-phosphate ophthalmic solution) and the KXL® System for corneal cross-linking, a minimally invasive outpatient procedure that combines the use of Vitamin B2 eye drops and ultra-violet (UV) light.

The approval of Photrexa Viscous, Photrexa and the KXL System offers an effective treatment for patients who, until recently, had no therapeutic options to limit the progression of this sight-threatening disease.

Don’t wait to call the eye doctor if you notice changes in your child’s vision! Ask about FDA approved cross-linking, clinically proven to limit the progression of this sight-threatening disease.

Cross-Linking

Learn more about this outpatient procedure

View our Living with Keratoconus Patient Brochure.

Patient FAQs

Discover answers to the most common questions surrounding cross-linking

Visit the Patient FAQ Section to learn more.

It is estimated that...

1 Out of Every 2,000

persons in the general population have Keratoconus1

You can find more information from the National Keratoconus Foundation.

1. Kennedy R. H., Bourne W. M., Dyer J. A. A 48-year clinical and epidemiologic study of keratoconus. The American Journal of Ophthalmology. 1986;101(3):267–273. doi: 10.1016/0002-9394(86)90817-2.

Corneal cross-linking provides patients a much-needed option to treat this debilitating disease. Patients suffering from progressive keratoconus can now receive a therapeutic treatment that has been rigorously tested and approved."

Mary Prudden, Executive Director for the National Keratoconus Foundation

What are Patients Saying? View Stories

Learn More Through Our Facebook Page

2 days ago

Living with KC

#FactFriday - While there is currently no cure for #keratoconus, available treatment options focus on improving vision and/or halting the progression of the disease. ow.ly/YhwA50vvEct ... See MoreSee Less

View on Facebook

3 days ago

Living with KC

If you're #LivingWithKC and traveling this summer, it's important to bring the right gear to properly care for your #contacts! What do you always have to remember to pack? ow.ly/4A6c50vvDQe ... See MoreSee Less

View on Facebook

5 days ago

Living with KC

Healthy Vision Tip: Know Your Family History ... See MoreSee Less

View on Facebook

Learn More Through Our Twitter Page

#FactFriday - While there is currently no cure for #keratoconus, available treatment options focus on improving vision and/or halting the progression of the disease. https://t.co/SbFXoikYj8

If you're #LivingWithKC and traveling this summer, it's important to bring the right gear to properly care for your #contacts! What do you always have to remember to pack? https://t.co/B4emdiCiCP

Shanice isn't letting her #keratoconus get in the way of her passion: playing football at a professional level. Visit our blog to read her #KCJourney and how she's able to manage her KC and remain on the field. https://t.co/VfLMfTred4

Load More...

Learn More Through Our Instagram

MA-00687B